ANTHELMINTIC ACTIVITY OF MITOMYCIN-A, MITOMYCIN-C, AND MITOMYCIN-F AGAINST HYMENOLEPIDID LARVAE IN TRIBOLIUM-CONFUSUM

被引：1
|
作者：
NOVAK, M [1 ]
KORNOVSKI, B [1 ]
KUNZ, KR [1 ]
机构：
[1] UNIV ARIZONA,DEPT PHARMACEUT SCI,TUCSON,AZ 85721
来源：
CANADIAN JOURNAL OF ZOOLOGY-REVUE CANADIENNE DE ZOOLOGIE | 1991年 / 69卷 / 06期
关键词：
D O I：
10.1139/z91-238
中图分类号：
Q95 [动物学];
学科分类号：
071002 ;
摘要：
Mitomycin analogues were tested against metacestode stages of Hymenolepis microstoma and H. nana developing in Tribolium confusum. The effects of the mitomycins varied according to both the drug and the species of the parasite. In general, the most effective compound was mitomycin C, followed by mitomycin A and then by mitomycin F. The efficacy of drugs improved further when sodium bicarbonate was added to the diet.
引用
收藏
页码：1715 / 1717
页数：3
相关论文
共 50 条
  • [31] FLUOROURACIL (F), ADRIAMYCIN (A) AND MITOMYCIN-C (M), FAM, FOR ADENOCARCINOMA OF UNKNOWN ORIGIN (AUO)
    MCKEEN, E
    SMITH, F
    HAIDAK, D
    BUTLER, T
    HOTH, D
    WOOLLEY, P
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 358 - 358
  • [32] FLUOROURACIL(F), ADRIAMYCIN(A) AND MITOMYCIN-C(M), FAM, FOR ADVANCED COLORECTAL AND PANCREATIC CANCER
    HALLER, D
    WOOLLEY, P
    LEVIN, B
    UENO, W
    MACDONALD, J
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 342 - 342
  • [33] ENHANCEMENT OF THE EFFECTIVENESS OF MITOMYCIN-C (MC) AGAINST HYPOXIC TUMOR-CELLS BY DICOUMAROL
    KEYES, SR
    ROCKWELL, S
    SARTORELLI, AC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 323 - 323
  • [34] MITOMYCIN-C COMBINATION THERAPY AGAINST MURINE TUMOR SYSTEMS - EFFECTIVENESS WITH CYCLOPHOSPHAMIDE AND METHOTREXATE
    MABEL, JA
    WODINSKY, I
    CANCER, 1983, 51 (04) : 600 - 605
  • [35] ACTIVITY OF MITOMYCIN C OTHER ANTIBIOTICS AND SERUM AGAINST LYSOGENIC BACTERIA
    MUSCHEL, LH
    SCHMOKER, K
    JOURNAL OF BACTERIOLOGY, 1966, 92 (04) : 967 - &
  • [36] ACTIVITY OF 5-FLUOROURACIL, MITOMYCIN-C, AND METHYL CCNU IN INOPERABLE ADENOCARCINOMA OF PANCREAS
    VAUGHN, C
    CHAPMAN, J
    CHINN, B
    WARD, D
    GROSHKO, G
    MANISCALCO, B
    REZNIK, S
    PIPER, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 49 - 52
  • [37] Comparison of the therapeutic effect of mitomycin-C ifosfamide-cisplatin (MIC) against mitomycin-C vinblastine-cisplatin (MVP) regimen in non-small cell lung cancer (NSCLC).
    Radosavljevic, V
    Kovcin, V
    Andric, Z
    Petrovic, N
    Ponomarev, D
    ANNALS OF ONCOLOGY, 2000, 11 : 117 - 117
  • [38] SYNERGISTIC ANTITUMOR-ACTIVITY OF MITOMYCIN-C AND CISPLATIN AGAINST GASTRIC-CANCER CELLS IN-VITRO
    SAIKAWA, Y
    KUBOTA, T
    KUO, TH
    KASE, S
    FURUKAWA, T
    TANINO, H
    ISHIBIKI, K
    KITAJIMA, M
    JOURNAL OF SURGICAL ONCOLOGY, 1993, 54 (02) : 98 - 102
  • [39] POTENTIATION OF ANTITUMOR-ACTIVITY OF MITOMYCIN-C BY VERAPAMIL IN EHRLICH ASCITES-CARCINOMA
    OSMAN, AM
    HAMADA, FMA
    ELAZIZ, AHA
    BADARY, OA
    HAMZA, SM
    FASEB JOURNAL, 1991, 5 (05): : A1261 - A1261
  • [40] TUMORICIDAL ACTIVITY OF PERITONEAL-EXUDATE CELLS FROM RATS TREATED WITH MITOMYCIN-C
    OGURA, T
    SHINDO, H
    NAMBA, M
    YAMAMURA, Y
    GANN, 1980, 71 (06): : 920 - 921
12345